UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm study Journal article
Jensen, Kristian H.Reveles, Urdanibia-Centelles, Olalla, Dam, Vibeke H., Köhler-Forsberg, Kristin, Frokjaer, Vibe G., Knudsen, Gitte M., Jørgensen, Martin B., Ip, Cheng T.. EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm study[J]. European Neuropsychopharmacology, 2024, 79, 59-65.
Authors:  Jensen, Kristian H.Reveles;  Urdanibia-Centelles, Olalla;  Dam, Vibeke H.;  Köhler-Forsberg, Kristin;  Frokjaer, Vibe G.; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:6.1/5.3 | Submit date:2024/02/22
Eeg  Escitalopram  Major Depressive Disorder  Ssri  Verbal Memory  
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:  Hu Y.-D.;  Xiang Y.-T.;  Fang J.-X.;  Zu S.;  Sha S.; et al.
Favorite | TC[WOS]:109 TC[Scopus]:117 | Submit date:2018/10/30
Escitalopram  Ketamine  Key Words Efficacy  Major Depression  Response  Tolerability